The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Observational study of the efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis.
 
Konstantin K Laktionov
No Relationships to Disclose
 
Alla L Arzumanyan
No Relationships to Disclose
 
Larisa V Bolotina
No Relationships to Disclose
 
Valeriy Vladimirovich Breder
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Natalia N Buevich
No Relationships to Disclose
 
Anastasia Danilova
No Relationships to Disclose
 
Elena A Filippova
No Relationships to Disclose
 
Anna Kornietskaya
No Relationships to Disclose
 
Mikhail M Kramchaninov
No Relationships to Disclose
 
Eugenia K Kushniruk
No Relationships to Disclose
 
Dilorom Hamidovna Latipova
No Relationships to Disclose
 
Daria A Lipatova
No Relationships to Disclose
 
Fedor Vladimirovich Moiseenko
No Relationships to Disclose
 
Tatiana P Nikitina
No Relationships to Disclose
 
Sergey Orlov
No Relationships to Disclose
 
Rashida Orlova
No Relationships to Disclose
 
Svetlana Protsenko
No Relationships to Disclose
 
Ksenia A Sarantseva
No Relationships to Disclose
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Tatyana I Ionova
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb